---
title: "avelumab - Merkel cell carcinoma"
sidebar: mydoc_sidebar
permalink: avelumabmerkelcellcarcinoma.html
toc: false 
---

{% include image.html url="images/avelumabmerkelcellcarcinoma.png" file="avelumabmerkelcellcarcinoma.png" alt="avelumabmerkelcellcarcinoma" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C000609138 | avelumab | Drug |
| UniProt:Q9NZQ7 | Programmed cell death 1 ligand 1 | Protein |
| GO:0036037 | Cytotoxic T-Cell activity | BiologicalProcess |
| GO:0008283 | Cell proliferation | BiologicalProcess |
| MESH:D015266 | Merkel cell carcinoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Avelumab | DECREASES ACTIVITY OF | Programmed Cell Death 1 Ligand 1 |
| Programmed Cell Death 1 Ligand 1 | NEGATIVELY REGULATES | Cytotoxic T-Cell Activity |
| Cytotoxic T-Cell Activity | NEGATIVELY REGULATES | Cell Proliferation |
| Cell Proliferation | POSITIVELY CORRELATED WITH | Merkel Cell Carcinoma |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB11945#mechanism-of-action](https://go.drugbank.com/drugs/DB11945#mechanism-of-action){:target="_blank"}